These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 21457345)

  • 1. Histone deacetylase-1 and -2 expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival.
    Theocharis S; Klijanienko J; Giaginis C; Rodriguez J; Jouffroy T; Girod A; Alexandrou P; Sastre-Garau X
    J Oral Pathol Med; 2011 Oct; 40(9):706-14. PubMed ID: 21457345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metallothionein expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patient survival.
    Theocharis S; Klijanienko J; Giaginis C; Rodriguez J; Jouffroy T; Girod A; Point D; Tsourouflis G; Sastre-Garau X
    Histopathology; 2011 Sep; 59(3):514-25. PubMed ID: 22034891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of DNA repair proteins, MSH2, MLH1 and MGMT in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients' survival.
    Theocharis S; Klijanienko J; Giaginis C; Rodriguez J; Jouffroy T; Girod A; Point D; Tsourouflis G; Sastre-Garau X
    J Oral Pathol Med; 2011 Mar; 40(3):218-26. PubMed ID: 21029181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of Hippo pathway effector TAZ in tongue squamous cell carcinoma: correlation with clinicopathological features and patients' prognosis.
    Wei Z; Wang Y; Li Z; Yuan C; Zhang W; Wang D; Ye J; Jiang H; Wu Y; Cheng J
    J Oral Pathol Med; 2013 Nov; 42(10):747-54. PubMed ID: 23551691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of cannabinoid CB1 and CB2 receptors expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients' survival.
    Theocharis S; Giaginis C; Alexandrou P; Rodriguez J; Tasoulas J; Danas E; Patsouris E; Klijanienko J
    Tumour Biol; 2016 Mar; 37(3):3647-56. PubMed ID: 26459312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of the histone demethylase LSD1 associates with cancer cell proliferation and unfavorable prognosis in tongue cancer.
    Yuan C; Li Z; Qi B; Zhang W; Cheng J; Wang Y
    J Oral Pathol Med; 2015 Feb; 44(2):159-65. PubMed ID: 25040359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor-γ in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival.
    Theocharis S; Klijanienko J; Giaginis C; Rodriguez J; Jouffroy T; Girod A; Point D; Tsourouflis G; Satre-Garau X
    J Cancer Res Clin Oncol; 2011 Feb; 137(2):251-9. PubMed ID: 20390425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ephrin receptor (Eph) -A1, -A2, -A4 and -A7 expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival.
    Theocharis S; Klijanienko J; Giaginis C; Alexandrou P; Patsouris E; Sastre-Garau X
    Pathol Oncol Res; 2014 Apr; 20(2):277-84. PubMed ID: 24022400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatty acid synthase expression in squamous cell carcinoma of the tongue: clinicopathological findings.
    Silva SD; Perez DE; Nishimoto IN; Alves FA; Pinto CA; Kowalski LP; Graner E
    Oral Dis; 2008 May; 14(4):376-82. PubMed ID: 18410580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Postoperative recurrence-related factors of 125 patients with cT1-2N0 squamous cell carcinoma of the oral tongue].
    Han JM; Wu GH; Zeng ZY; Chen FJ; Chen WK; Li H; Song M; Sun CZ
    Ai Zheng; 2007 Jun; 26(6):661-5. PubMed ID: 17562277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological features and proliferation markers in tongue squamous cell carcinomas.
    Gueiros LA; Coletta RD; Kowalski LP; Lopes MA
    Int J Oral Maxillofac Surg; 2011 May; 40(5):510-5. PubMed ID: 21277167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular signal-regulated kinase (ERK) expression and activation in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival.
    Theocharis S; Kotta-Loizou I; Klijanienko J; Giaginis C; Alexandrou P; Dana E; Rodriguez J; Patsouris E; Sastre-Garau X
    Tumour Biol; 2014 Jul; 35(7):6455-65. PubMed ID: 24682903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of novel oncogenes squamous cell carcinoma-related oncogene and phosphatidylinositol 3-kinase p110alpha in squamous cell carcinoma of the oral tongue.
    Estilo CL; O-Charoenrat P; Ngai I; Patel SG; Reddy PG; Dao S; Shaha AR; Kraus DH; Boyle JO; Wong RJ; Pfister DG; Huryn JM; Zlotolow IM; Shah JP; Singh B
    Clin Cancer Res; 2003 Jun; 9(6):2300-6. PubMed ID: 12796399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FAK and Src expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival.
    Theocharis S; Klijanienko J; Giaginis C; Alexandrou P; Patsouris E; Sastre-Garau X
    J Cancer Res Clin Oncol; 2012 Aug; 138(8):1369-77. PubMed ID: 22488171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EMMPRIN expression in tongue squamous cell carcinoma.
    Huang Z; Huang H; Li H; Chen W; Pan C
    J Oral Pathol Med; 2009 Jul; 38(6):518-23. PubMed ID: 19473445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and Clinical Significance of Concomitant FAK/SRC and p-Paxillin in Mobile Tongue Squamous Cell Carcinoma.
    Theocharis S; Kotta-Loizou I; Giaginis C; Alexandrou P; Danas E; Tsourouflis G; Tsoukalas N; Coutts RH; Tasoulas J; Klijanienko J
    Anticancer Res; 2017 Mar; 37(3):1313-1319. PubMed ID: 28314297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteopontin as biomarker in early invasion by squamous cell carcinoma in tongue.
    Matsuzaki H; Shima K; Muramatsu T; Ro Y; Hashimoto S; Shibahara T; Shimono M
    J Oral Pathol Med; 2007 Jan; 36(1):30-4. PubMed ID: 17181739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for late cervical lymph node metastases in patients with stage I or II carcinoma of the tongue.
    Kurokawa H; Yamashita Y; Takeda S; Zhang M; Fukuyama H; Takahashi T
    Head Neck; 2002 Aug; 24(8):731-6. PubMed ID: 12203797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive and negative regulation of podoplanin expression by TGF-β and histone deacetylase inhibitors in oral and pharyngeal squamous cell carcinoma cell lines.
    Ohta M; Abe A; Ohno F; Hasegawa Y; Tanaka H; Maseki S; Kondo E; Kurita K; Nakanishi H
    Oral Oncol; 2013 Jan; 49(1):20-6. PubMed ID: 22840788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Survival analysis of 229 patients with advanced squamous cell carcinoma of the oral tongue].
    Yang AK; Liu TR; Chen FJ; Ma XF; Guo ZM; Song M; Li QL; Zeng ZY
    Ai Zheng; 2008 Dec; 27(12):1315-20. PubMed ID: 19080001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.